top of page

A breakthrough in

GLAUCOMA IMPLANTS

Zero bleb complications

No Mitomycin C required

Superior efficacy

Highly cost effective

"The OptiShunt has tremendous potential to overcome the limitations of current glaucoma procedures. It may become one of the leading methods to manage glaucoma surgically in the future."

PROF. SANJAY ASRANI

DIRECTOR OF GLAUCOMA, DUKE EYE CENTRE, DUKE UNIVERSITY

RE-DEFINING

the treatment of

GLAUCOMA

Winner

Winner

Runner up

Finalist

Awards

Featured

bottom of page